Enovis ENOV
NYSE ENOV
$26.13 -0.37 (-1.40%)
At close: Aug 20, 2026 · 2:37 PM UTC

Enovis (ENOV) Change in Accured Expenses (2010 - 2011)

Enovis (ENOV) posted quarterly Change in Accured Expenses of -$9.4 million for Q4 2011, down 159.9% year-over-year from $15.7 million in Q4 2010, and down 1109.98% quarter-over-quarter from $932000.0 in Q3 2011.

Enovis (ENOV) Change in Accured Expenses (2010 - 2011) Analysis & Trends

Enovis (ENOV) has reported Change in Accured Expenses for 2 consecutive years, with -$9.4 million the latest figure, recorded in Q4 2011.

  • In Q4 2011, Change in Accured Expenses fell 159.9% year-over-year to -$9.4 million; the TTM figure through Dec 2011 stood at $16.0 million (changed N/A YoY), while the FY2011 annual figure was -$10.9 million, down 150.1% from the prior year.
  • Change in Accured Expenses eased to -$9.4 million in Q4 2011 per ENOV's latest filing, from $932000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $15.7 million in Q4 2010 and bottomed at -$9.4 million in Q4 2011.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Abbott Laboratories 199.63 Bn 194.02 Bn 7.27 Bn -
2 Stryker 127.42 Bn 123.95 Bn 4.50 Bn 298.00 Mn
3 Medtronic 118.97 Bn 109.75 Bn 6.41 Bn 123.00 Mn
4 Boston Scientific 73.39 Bn 72.85 Bn 3.85 Bn 234.00 Mn
5 Edwards Lifesciences 51.97 Bn 47.72 Bn 1.35 Bn 123.70 Mn
6 Dexcom 34.32 Bn 32.37 Bn 830.00 Mn 112.90 Mn
7 GE HealthCare Technologies 33.76 Bn 31.65 Bn 2.18 Bn 19.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 43.01 Mn
9 Steris 23.04 Bn 22.56 Bn 684.20 Mn 4.80 Mn
10 Enovis 1.51 Bn 1.50 Bn 359.25 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2011 -9.41 Mn
Dec 31, 2011 -9.41 Mn
Sep 30, 2011 932,000.00
Sep 30, 2011 932,000.00
Dec 31, 2010 15.72 Mn
Dec 31, 2010 15.72 Mn
Oct 1, 2010 8.74 Mn
Oct 1, 2010 8.74 Mn